Wired Future Lab, mawonekedwe aulere a digito otseguka kwa ndemanga zilizonse ndi gawo latsopano mogwirizana ndi Viatris.
Laboratory ya tsogolo logwirizana, mtundu wa chidziwitso chaulere cha digito ndi kutsegulidwa kwa onse, abwereranso ndi msonkhano watsopano womwe umayang'ana zaukadaulo pazamankhwala komanso kufunikira kwa mankhwala osagwiritsidwa ntchito patent, ma biosimilars ndi ofanana nawo kuti ndalama zogwiritsira ntchito zaumoyo zikhale zokhazikika ndikukwaniritsa zosowa za umoyo wa nzika komanso makamaka odwala khansa.
Gawo lachiwiri, lokonzekera tsiku loyamba la sabata lachisanu ndi chitatu la Novembala kuyambira 14:30 p.m. mpaka 16:15 p.m. likukhamukira pamalo opatulidwira, limakonzedwa mogwirizana ndi viatris, mtundu watsopano wabizinesi wapadziko lonse lapansi womwe umagwira ntchito pazaumoyo (wobadwa mu 2020 kuchokera pakuphatikizidwa kwa Mylan ndi Upjohn), komanso kupezeka ku Italy, omwe mbiri yawo imaphatikizapo zinthu zopitilira 1,400 m'magawo osiyanasiyana azachipatala, kuthana ndi matenda onsewa. ndi matenda osapatsirana osatha, kuphatikiza zodziwika bwino komanso zapadziko lonse lapansi, mankhwala ofanana ndi biosimilar, parapharmaceuticals ndi thanzi la ogula. Ntchito ya Viatris ndikupatsa mphamvu anthu padziko lonse lapansi kuti azikhala athanzi panjira iliyonse.
Ndi chifukwa chake kampaniyo idaganiza zoyambitsa Innovability pa ntchito ya oncology, yomwe cholinga chake chachikulu, monga momwe mawuwo amanenera, ndikukwaniritsa zatsopano, chifukwa chake kukhazikitsidwa kwa machitidwe atsopano ndi njira zatsopano, kudzera pakukhazikika, zofunika kuti zitheke. kuonetsetsa ubwino wa m'badwo wamakono popanda kusokoneza wa mibadwo yamtsogolo. Izi zitha kulola kuti ndalama zomwe zasungidwa zikhazikitsidwenso, azipatala ndi azaumoyo onse, mwa ogwira ntchito, mautumiki ndi thandizo, zopatsa chidwi komanso kupereka moyo ku mkangano wamankhwala osavomerezeka, ma biosimilars ndi ma generic.
Monga gawo la Wired Future Lab, Laura Borgna, Mtsogoleri wa Health Centers ndi Policy ndi Market Access Business Unit ku Viatris, idzawonetsa masomphenya ndi ndondomeko ya Gulu pa mankhwala a biosimilar ndi ofanana ndi mankhwala, komanso ndi cholinga cholimbikitsa kukhazikika kwa oncology. Kukambitsirana kumakhalanso kofulumira kwambiri potengera momwe zinthu ziliri pano: chifukwa chosowa kuwunika panthawi ya mliri, chowopsa ndichakuti ma neoplasms ambiri amapezeka ndipo adzadziwika pamlingo wapamwamba kwambiri ndipo zida zambiri zidzafunika kuwachiritsa. . odwala omwe ali ndi matenda ovuta kwambiri, pamene amafika mochedwa. Kuphatikiza pa izi, m'zaka zingapo zikubwerazi, ma biologics angapo okhazikika adzataya chitetezo chawo cha patent, zomwe zimakhudzana ndi chitukuko cha biosimilars.
Mkhalidwe waukadaulo ku Italy ndi ku Europe udzakambidwanso patebulo lozungulira ndi Francesco Perrone, director of the complex trial trials structure of Pascale National Cancer Institute of Naples and membala wa national council of Aiom (Italian Association of Medical Oncology), Julie Marécha-Jamil, director of Policy and Science of Drug Biosimilars for Europe , Rosa Giuliani, oncologist ku Clatterbridge Cancer Center ku Liverpool. Mu 15, European Union idavomereza mankhwala oyamba a biosimilar, koma kodi zochitikazo zidasintha bwanji zaka 4 pambuyo pake pankhani ya ntchito komanso momwe zimakhudzira machitidwe azaumoyo? Kuphatikiza pa izi, mu Novembala XNUMX, Commission idatengera Njira Yamankhwala, yomwe cholinga chake ndi kukonzanso zowongolera pamundawu ndipo, pakati pa mizati yake XNUMX, kuwonetsetsa kuti odwala ali ndi mwayi wopeza mankhwala otsika mtengo komanso mayankho pazosowa zopanda chithandizo. minda ya antimicrobial resistance, khansa, matenda akunja) kuteteza kukhazikika kwachuma kwa machitidwe azaumoyo (pakali pano akufunsidwa ndi anthu).
Kukambiranaku kudzasonkhanitsa zikhulupiliro za anthu ndi maphwando omwe ali ndi chidwi, chifukwa chake ochita masewera osiyanasiyana: kulumikizana ndi malingaliro ali pakati pa gawo lachitatu ndi lomaliza la chochitikacho poyerekeza pakati pawo. Anna Plana Mandorino, mlembi wamkulu wa Cittadinanzattiva, ndi Silvia Bencivelli, wolemba mbiri za sayansi komanso wolankhula pa wailesi ndi pa TV.. The dziko la sayansi kulankhulana ndi mayanjano kukambirana za zosowa za nzika mfundo za moyo wabwino ndi thanzi, za kuzindikira ndi zochita zomwe zilipo kale: mu 12, malinga ndi deta Egualia (kale Assogenerici), Biosimilars analembetsa kuwonjezeka kwa XNUMX kumwa mowa XNUMX %.
